![]() |
|
|
|
Preclinical study managementTaking the effort out of study reports |
05 October 2008 BioRails Boot Camp 2008The first training boot camp will be held 6th - 9th October. Attendees will recieve comprehensive training on the latest data management techniques using BioRails. If you're interested in attending a future training camp please contact us. 25 September 2008 Exhibition at Drug Discovery 2008Located in the innovation zone at this busy meeting, The Edge joined a number of emerging new companies displaying a range of new innovative solutions challenging the dominance of more established players in the market. 05 August 2008 Team ExpandingIn response to an increased demand for our services and software we've vacancies to expand the team. 22 June 2008 The Edge release cheminformatics nodes4knimeThe first release of cheminformatics nodes for the knime platform have been released. 21 November 2007 Lundbeck Pharmaceuticals select BioRails as the biologist's ELNBioRails will be deployed globally to support all biological research.
|
||||||||||||||
|
Managing studies from preclinical studies generates a number of challenges:
BioRails unique combination of flexible data management and discovery project management tool make it an ideal solution for preclinical research. Traditional data management solutions are too rigid for this dynamic research environment. Electronic laboratory notebooks provide the flexibility but at the sacrifice of losing the structure of data making it difficult to exploit. BioRails provides a structured data management platform for preclinical studies supporting research by facilitating:
MorphIt is a unique multi-dimensional spreadsheet allowing protocols to be adapted and changed during experiments. Data import from instruments and reader files are combined with summarisation and statistical analysis making it an ideal tool for complex preclinical studies. The combination of flexible data capture and analysis with a robust and scalable data management platform makes BioRails and MorphIt an ideal solution for preclinical studies.
|
|
|
|||||||||||||
|
|
|
|
|||||||||||
|
|
|||||||||||||